Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
290
-
Total 13F shares, excl. options
-
232M
-
Shares change
-
+17.1M
-
Total reported value, excl. options
-
$1.86B
-
Value change
-
+$106M
-
Put/Call ratio
-
1.31
-
Number of buys
-
172
-
Number of sells
-
-116
-
Price
-
$8.02
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2024
355 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2024.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 290 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 232M shares
of 334M outstanding shares and own 69.54% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (26M shares), PERCEPTIVE ADVISORS LLC (25.9M shares), MHR FUND MANAGEMENT LLC (24M shares), BlackRock Inc. (21.2M shares), STATE STREET CORP (12.6M shares), Avoro Capital Advisors LLC (11.7M shares), Soleus Capital Management, L.P. (7.55M shares), GEODE CAPITAL MANAGEMENT, LLC (5.79M shares), Artisan Partners Limited Partnership (5.11M shares), and Balyasny Asset Management L.P. (4.54M shares).
This table shows the top 290 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.